oxybutynin has been researched along with glycopyrrolate in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Levin, RM; Wein, AJ | 1 |
| Lefrandt, JD; Maurer, JM | 1 |
| Baker, DM; Nicholas, R; Quddus, A | 1 |
| de Troya-Martín, M; Del Boz, J; Millán-Cayetano, JF; Rivas-Ruiz, F | 1 |
| Fischer, R; Liu, D; Prouty, ME | 1 |
| Del Boz, J; García-Souto, F; Polo-Padillo, J; Rivas-Ruiz, F | 1 |
| Cadwgan, J; Cole, M; Colver, AF; O'Hare, AE; Parr, JR; Pennington, L; Stocken, D; Todhunter, E; Tuffrey, C; Williams, J | 1 |
1 review(s) available for oxybutynin and glycopyrrolate
| Article | Year |
|---|---|
Treatment of Primary Craniofacial Hyperhidrosis: A Systematic Review.
Topics: Botulinum Toxins, Type A; Cholinergic Antagonists; Facial Dermatoses; Ganglionectomy; Glycopyrrolate; Head; Humans; Hyperhidrosis; Mandelic Acids; Neck; Neuromuscular Agents | 2015 |
1 trial(s) available for oxybutynin and glycopyrrolate
| Article | Year |
|---|---|
Drooling Reduction Intervention randomised trial (DRI): comparing the efficacy and acceptability of hyoscine patches and glycopyrronium liquid on drooling in children with neurodisability.
Topics: Administration, Oral; Adolescent; Child; Child, Preschool; Cholinergic Antagonists; Drug Administration Schedule; Female; Follow-Up Studies; Glycopyrrolate; Humans; Male; Nervous System Diseases; Prospective Studies; Scopolamine; Sialorrhea; Single-Blind Method; Transdermal Patch; Treatment Outcome | 2018 |
5 other study(ies) available for oxybutynin and glycopyrrolate
| Article | Year |
|---|---|
Direct measurement of the anticholinergic activity of a series of pharmacological compounds on the canine and rabbit urinary bladder.
Topics: Animals; Atropine; Binding, Competitive; Dicyclomine; Dogs; Female; Glycopyrrolate; Imipramine; In Vitro Techniques; Mandelic Acids; Parasympatholytics; Propantheline; Rabbits; Radioligand Assay; Receptors, Cholinergic; Receptors, Muscarinic; Urinary Bladder | 1982 |
Oxybutynin for hyperhidrosis.
Topics: Adolescent; Adult; Depression; Female; Glycopyrrolate; Humans; Hyperhidrosis; Male; Mandelic Acids; Raynaud Disease; Sympathectomy; Thoracic Nerves | 2007 |
Oral glycopyrrolate after the failure of oral oxybutynin in the treatment of primary hyperhidrosis.
Topics: Administration, Oral; Adolescent; Adult; Aged; Child; Drug Administration Schedule; Female; Glycopyrrolate; Humans; Hyperhidrosis; Male; Mandelic Acids; Middle Aged; Muscarinic Antagonists; Prospective Studies; Treatment Outcome; Young Adult | 2017 |
Glycopyrrolate-induced craniofacial compensatory hyperhidrosis successfully treated with oxybutynin: report of a novel adverse effect and subsequent successful treatment.
Topics: Adult; Deprescriptions; Female; Glycopyrrolate; Humans; Hyperhidrosis; Mandelic Acids; Muscarinic Antagonists; Treatment Outcome | 2016 |
Survival study of treatment adherence by patients given oral glycopyrrolate for hyperhidrosis following treatment failure with oral oxybutynin.
Topics: Adult; Female; Glycopyrrolate; Humans; Hyperhidrosis; Mandelic Acids; Muscarinic Antagonists; Prospective Studies; Treatment Adherence and Compliance; Treatment Failure; Treatment Outcome | 2020 |